Vericel Corp (VCEL) Stock Analysis
Verdict: WATCH (do not buy)
MACI adoption fuels rare biopharma profitability, but a trailing P/E of 86x leaves tight safety margins if growth slows.
Investment score: 59/100
Analysis as of
Is Vericel Corp stock worth reviewing? The TradeMates thesis
Vericel offers verified commercial traction with MACI and Epicel, but a high P/E of 86.0x and recent executive insider selling justify a cautious HOLD stance.
7-factor investment score
- Valuation: 35/100 (weight 20%)
- Financial Health: 75/100 (weight 15%)
- Technical Momentum: 55/100 (weight 15%)
- Earnings Quality: 85/100 (weight 15%)
- Insider Sentiment: 25/100 (weight 10%)
- Analyst Consensus: 80/100 (weight 10%)
- Risk-Adjusted Return: 60/100 (weight 15%)
Vericel Corp opportunities and risks
What speaks for VCEL
- Sustained MACI volume expansion in sports medicine surgery
What speaks against VCEL
- Extreme valuation sensitivity to revenue growth slowdowns
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| VCEL | 82.2x | 6.6x | 51.7x | 74.6% | 7.9% | 2.5% |
| SRPT | n/a | 1.1x | n/a | 58.6% | -6.9% | -6.1% |
| VRDN | n/a | 34.8x | n/a | 99.6% | -544.1% | -13.5% |
| KOD | n/a | 0.0x | n/a | 0.0% | 0.0% | -7.7% |
| AGIO | n/a | 20.4x | n/a | 87.9% | -418.2% | -18.2% |
| ZBIO | n/a | 2021.8x | n/a | -5972.6% | -48438.4% | -11.2% |
| Peer median | n/a | 20.4x | n/a | 58.6% | -418.2% | -11.2% |
Frequently asked questions about Vericel Corp (VCEL)
Is VCEL stock a good investment?
The TradeMates model rates Vericel Corp as WATCH (do not buy) with an investment score of 59/100. Vericel offers verified commercial traction with MACI and Epicel, but a high P/E of 86.0x and recent executive insider selling justify a cautious HOLD stance. This is algorithmic model output, not personal investment advice.
Is VCEL stock a buy?
The TradeMates model verdict for VCEL is WATCH (do not buy) with an investment score of 59/100. Treat this as a model signal to review, not a personal buy recommendation.